The Role of Topylal in Rate Control of AFib RVR

It's not uncommon though for patients to present with atrial fibrillation and have a history of heart failure. Usually it's recommended to avoid deltaizum as non-dehydroperidine calcium channel blockers can exacerbate heart failure or cause other associated cardiac risk. This is a retrospective single center cohort study from Marino Valley, California published in the American Journal of Emergency Medicine. Rate control achieved at 30 minutes was not significantly different, 40% in mitopolom versus 47% of the topylal patients.